Enanta Pharmaceuticals (ENTA) Share-based Compensation (2012 - 2026)
Enanta Pharmaceuticals' Share-based Compensation came in at $3.68 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 11.8% from $4.18 million a year earlier and down 1.7% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Share-based Compensation (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Enanta Pharmaceuticals reported Share-based Compensation of $15.28 million, down 31.3% year-over-year; for FY2025 (ended Sep 30, 2025), it was $18.57 million, down 30.7% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of -1.1% (FY2020 to FY2025).
- Going back by fiscal year, Share-based Compensation was $26.8 million in FY2024 (-5.0%), $28.22 million in FY2023 (+4.6%), $26.97 million in FY2022 (+28.5%) and $20.99 million in FY2021 (+7.2%).
- The fiscal Q3 2026 figure represents the lowest quarterly Share-based Compensation since fiscal Q2 2018.
- Year-over-year, Share-based Compensation has declined for seven consecutive quarters, with an average decline of 20.8% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q3 2022 (growth of 38.9%), and the weakest in fiscal Q4 2025 (a decline of 47.7%).
- Business Quant data shows ENTA's Share-based Compensation at $3.75 million (Q2 2026), $3.81 million (Q1 2026) and $4.03 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - | 3.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.68 Mn |
| Mar 31, 2026 | 3.75 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 4.69 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 6.72 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 7.36 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 6.83 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 6.47 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Sep 30, 2021 | 5.35 Mn |
Enanta Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();